Back to search

Inhibition of Transporter-Mediated Hepatic Uptake as a Mechanism for Drug-Drug Interaction between Cerivastatin and Cyclosporin A

Data up to Jan 2025

Published2003
Citations344
References40

Total Citations Per Year

Abstract

References (40)

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

A pharmacokinetic analysis program (multi) for microcomputer.

1981 • 2,465 citations

Pentoxifylline

1987 • 1,768 citations

Molecular Identification and Characterization of Novel Members of the Human Organic Anion Transporter (OATP) Family

2000 • 636 citations

A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)

1999 • 630 citations

A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane

2000 • 611 citations

Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1

1999 • 546 citations

Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide

2000 • 516 citations

Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver.

1998 • 497 citations

Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.

1994 • 390 citations

Cryopreserved human hepatocytes: characterization of drug-metabolizing activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug–drug interaction potential

1999 • 295 citations

Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins

2002 • 286 citations

Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood

1982 • 271 citations

Transcellular Transport of Organic Anions Across a Double-transfected Madin-Darby Canine Kidney II Cell Monolayer Expressing Both Human Organic Anion-transporting Polypeptide (OATP2/SLC21A6) and Multidrug Resistance-associated Protein 2 (MRP2/ABCC2)

2002 • 232 citations

Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes.

2001 • 211 citations

Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney

2002 • 176 citations

Clinical Pharmacokinetics of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors

1996 • 168 citations

A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor.

2000 • 162 citations

Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients

1999 • 157 citations

Gemfibrozil

1988 • 145 citations

Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

1999 • 122 citations

Clinical Pharmacokinetics of Cerivastatin

2000 • 118 citations

Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients.

1993 • 113 citations

Isolation and culturing of hepatocytes from human livers

1992 • 113 citations

Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport.

2002 • 108 citations

Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4.

2000 • 95 citations

The xenobiotic inhibitor profile of cytochrome P4502C8

2000 • 87 citations

Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes.

1998 • 76 citations

Drug Transporters: Their Role and Importance in the Selection and Development of New Drugs

2002 • 74 citations

Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture

1992 • 65 citations

Exercise and diet reduce risk of diabetes, US study shows

2001 • 63 citations

Bayer decides to withdraw cholesterol lowering drug.

2001 • 57 citations

Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin

1998 • 53 citations

Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.

2001 • 53 citations

Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes.

1999 • 50 citations

Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.

2000 • 23 citations

Assignment<footref rid="foot01"><sup>1</sup></footref> of liver-specific organic anion transporter (SLC22A7) to human chromosome 6 bands p21.2→p21.1 using radiation hybrids

2000 • 14 citations

Carrier-Mediated Uptake of Cerivastatin in Primary Cultured Rat Hepatocytes.

2000 • 6 citations

QUANTITATIVE PREDICTION: METABOLISM, TRANSPORT IN THE LIVER

1999 • 2 citations

UK government launches anti-tobacco campaign for Asians

2001 • 2 citations

Cited By (0)

Loading...
Inhibition of Transporter-Mediated Hepatic Uptake as a Mechanism for Drug-Drug… (2003) – Journal of Pharmacology and Experimental Therapeutics | Metascience Observatory Explorer